EU Health Policy Platform Calls for Proposals: 2021 Thematic Networks
The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is to produce a Joint Statement within a year, summarising the common position of a group of stakeholder organisations on one of the following selected public health areas:
Read more ...
Commission Opens First European Innovation Council Calls Worth €1 Billion
Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over €1 billion aims to help scale up start-ups and small and medium-sized businesses that have the potential to achieve high impact. While over half of the funding is open to breakthrough innovations in any field, €495 million are earmarked for innovations that support the European Green Deal as well as digital and health technologies.
Read more ...
Accelerating Data Solutions to Save LIVES from COVID-19
The consortium of COVID-X announces the launch of the 1st Open Call framed in a 2-year initiative that will invest 4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.
Read more ...
Open Call SC1-HCO-18-2020: Developing Methodological Approaches for Improved Clinical Investigation and Evaluation of High-Risk Medical Devices
In May 2017, a new Regulation on medical devices, Regulation (EU) 2017/745 entered into force that will come into effect in spring 2020. This new Regulation sets forth reinforced rules for the generation of clinical evidence: for instance, clinical investigations for high-risk devices will be compulsory and the requirements regarding the clinical evaluation throughout the product lifetime are more stringent.
Open Call SC1-HCO-19-2020: Reliable and Accessible Information on Cell and Gene-Based Therapies
Cell and gene-based therapies have the potential to treat many debilitating diseases and conditions. However, the pace of their clinical development does not meet public expectations. They face difficulties reaching patients because inter alia the complexity and costs of product development, regulatory hurdles and the non-harmonized procedures for reimbursements. In addition, there are concerns over patient safety due to the use of unproven treatments.
Read more ...
The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is to produce a Joint Statement within a year, summarising the common position of a group of stakeholder organisations on one of the following selected public health areas: 